Fig. 4From: Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosisLong chain acylcarnitines in samples of VLCADD patients versus controls; *ā=āsignificant difference pĀ <ā0.05Back to article page